Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts

Uwe Platzbecker; Valeria Santini; Rami S. Komrokji; Amer M. Zeidan; Guillermo Garcia-Manero; Rena Buckstein; Dimana Miteva; Karen Keeperman; Natalia Holot; Jose Alberto Nadal; Yinzhi Lai; Sadanand Vodala; Barbara Rosettani; Ana Carolina Giuseppi; Aylin Yucel; Pierre Fenaux

doi:10.1038/s41375-023-02031-7

Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts

Uwe Platzbecker, Valeria Santini, Rami S. Komrokji, Amer M. Zeidan, Guillermo Garcia-Manero, Rena Buckstein, Dimana Miteva, Karen Keeperman, Natalia Holot, Jose Alberto Nadal, Yinzhi Lai, Sadanand Vodala, Barbara Rosettani, Ana Carolina Giuseppi, Aylin Yucel, Pierre Fenaux

Leukemia

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	2314-2318
Number of pages	5
Journal	Leukemia
Volume	37
Issue number	11
DOIs	https://doi.org/10.1038/s41375-023-02031-7
State	Published - Nov 2023

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-023-02031-7

Cite this

Platzbecker, U., Santini, V., Komrokji, R. S., Zeidan, A. M., Garcia-Manero, G., Buckstein, R., Miteva, D., Keeperman, K., Holot, N., Nadal, J. A., Lai, Y., Vodala, S., Rosettani, B., Giuseppi, A. C., Yucel, A., & Fenaux, P. (2023). Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts. Leukemia, 37(11), 2314-2318. https://doi.org/10.1038/s41375-023-02031-7

Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts. / Platzbecker, Uwe; Santini, Valeria; Komrokji, Rami S. et al.
In: Leukemia, Vol. 37, No. 11, 11.2023, p. 2314-2318.

Research output: Contribution to journal › Article › peer-review

Platzbecker, U, Santini, V, Komrokji, RS, Zeidan, AM, Garcia-Manero, G, Buckstein, R, Miteva, D, Keeperman, K, Holot, N, Nadal, JA, Lai, Y, Vodala, S, Rosettani, B, Giuseppi, AC, Yucel, A & Fenaux, P 2023, 'Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts', Leukemia, vol. 37, no. 11, pp. 2314-2318. https://doi.org/10.1038/s41375-023-02031-7

@article{2e439baafa994edd91c50aa4d3dec00c,

title = "Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts",

author = "Uwe Platzbecker and Valeria Santini and Komrokji, {Rami S.} and Zeidan, {Amer M.} and Guillermo Garcia-Manero and Rena Buckstein and Dimana Miteva and Karen Keeperman and Natalia Holot and Nadal, {Jose Alberto} and Yinzhi Lai and Sadanand Vodala and Barbara Rosettani and Giuseppi, {Ana Carolina} and Aylin Yucel and Pierre Fenaux",

year = "2023",

month = nov,

doi = "10.1038/s41375-023-02031-7",

language = "English (US)",

volume = "37",

pages = "2314--2318",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts

AU - Platzbecker, Uwe

AU - Santini, Valeria

AU - Komrokji, Rami S.

AU - Zeidan, Amer M.

AU - Garcia-Manero, Guillermo

AU - Buckstein, Rena

AU - Miteva, Dimana

AU - Keeperman, Karen

AU - Holot, Natalia

AU - Nadal, Jose Alberto

AU - Lai, Yinzhi

AU - Vodala, Sadanand

AU - Rosettani, Barbara

AU - Giuseppi, Ana Carolina

AU - Yucel, Aylin

AU - Fenaux, Pierre

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85172216201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85172216201&partnerID=8YFLogxK

U2 - 10.1038/s41375-023-02031-7

DO - 10.1038/s41375-023-02031-7

M3 - Article

C2 - 37752285

AN - SCOPUS:85172216201

SN - 0887-6924

VL - 37

SP - 2314

EP - 2318

JO - Leukemia

JF - Leukemia

IS - 11

ER -

Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this